- Featured Product
- KD/KO Validated
ACLY Monoklonaler Antikörper
ACLY Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgM
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1E10D5
Kat-Nr. : 67166-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
67166-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA ACLY und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Maus / IgM |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | ACLY fusion protein Ag7709 |
| Vollständiger Name | ATP citrate lyase |
| Berechnetes Molekulargewicht | 121 kDa |
| Beobachtetes Molekulargewicht | 120 kDa |
| GenBank-Zugangsnummer | BC006195 |
| Gene symbol | ACLY |
| Gene ID (NCBI) | 47 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
ACLY(ATP-citrate synthase) is also named as ACL. It is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA. ACLY serves as not only a target in oxygenated cells for suppression of lipid synthesis and histone acetylation, but also as a susceptible target in hypoxic cells to restore inhibition of glycolysis. In nonsmall cell lung carcinoma and hepatocellular carcinoma, ACLY is overexpressed compared with normal parenchyma suggesting that ACLY may represent a common target among highly malignant tumors(PMID:19795461). This protein has 2 isoforms produced by alternative splicing.













